🧭 When to suspect
Suspect Clostridioides difficile infection (CDI) in any patient who develops new diarrhoea (Bristol Stool type 5–7) during, or in the weeks following (up to around 8 weeks after), a course of antibiotics.
C. difficile – reclassified from Clostridium to Clostridioides in 2016 – is a spore-forming, toxin-producing anaerobe that overgrows when antibiotics disrupt the normal gut flora. In its severe form it causes pseudomembranous colitis.
The antibiotics most strongly associated are the “4 Cs”, though any antibiotic can trigger it:
• Clindamycin
• Cephalosporins
• Co-amoxiclav
• Ciprofloxacin (fluoroquinolones)
Risk is higher with:
• Increasing age (> 65)
• Recent hospitalisation or care-home residence
• Proton pump inhibitor (PPI) use
• Immunosuppression
• Previous CDI
For every case, three assessments drive management:
• Whether it is a first or further episode (relapse < 12 weeks, recurrence > 12 weeks after symptom resolution)
• The severity
• Individual risk factors for complications or recurrence
| Severity (PHE) | Defining features | Action |
|---|---|---|
| Mild | • Normal white cell count (WCC) • Typically < 3 loose stools/day |
• Treat in community • Oral vancomycin • Safety-net |
| Moderate | • Raised WCC < 15 × 10⁹/L • Typically 3–5 loose stools/day |
• Treat in community • Oral vancomycin • Closer review |
| Severe | WCC > 15 × 10⁹/L, or creatinine > 50% above baseline, or temp > 38.5°C, or severe colitis | Urgent specialist advice ± admission |
| Life-threatening | Hypotension, partial/complete ileus, toxic megacolon, or CT evidence of severe disease | • 999 or emergency admission • Surgical + specialist input |
Note that for a first episode, severity changes the urgency and monitoring, not the first-line drug – mild, moderate and severe disease all receive oral vancomycin.
Source: NICE NG199 · UKHSA
🔒 Sign up free to read the full topic
You're viewing a free preview. Create a free account to unlock the rest.
Sign up free →Sample topics are open to everyone in the Free Sample Bundle.